CD8A and cancer: Using currently available advanced technology, we demonstrate, similar to the findings by Galon et al. in this cancer subtype, that an activated immune environment (including CD8 T cells but also dendritic cells, tertiary lymphoid structures, among others) may be associated with improved patient prognosis.